Method for preparing entecavir and intermediate used therein
AssigneeHanmi Science Co., Ltd.
InventorsJae Heon Lee, Gha Seung Park, Jin Hee Kim, Tae Jin Choi, Ji Eun Lee, Jung Hee Han, Hyo Jeong Bang, Sun Young Jung, Young Kil Chang, Gwan Sun Lee, Maeng Sup Kim
Life of this patent
Estimating the term…
Abstract
Disclosed are a novel, high-yield method for preparing entecavir and intermediates used therein.
Claims24
A method for preparing entecavir of formula (I), comprising the steps of:
- (a) hydrolyzing an α-exomethylene derivative of formula (II) to obtain a compound of formula (III);
- (b) carrying out a Mitsunobu reaction of the compound of formula (III) with a purine derivative of formula (IV) to obtain a nucleoside compound of formula (V);
- (c) subjecting the nucleoside compound of formula (V) to a reaction with tetrabutyl ammonium fluoride to obtain a compound of formula (VI);
- and
- (d) hydrolyzing the compound of formula (VI):
- wherein
- R1 and R2 are each independently a hydroxy-protecting group, or R1 and R2 are fused together to form a cyclic hydroxy-protecting group;
- R3 is benzoyl or arylbenzoyl;
- and
- X is halogen or benzyloxy.
A solvate of crystalline entecavir dimethylformamide of formula (XIV) whose X-ray diffraction spectrum obtained using Cu-Kα radiation shows peaks having a peak intensity of 10% or more at diffraction angles (2θ±0.2) of 10.2, 14.4, 14.5, 16.6, 17.9, 18.8, 19.3, 19.8, 21.4, 21.9, 24.5, 25.5, 25.8, 26.7, 29.3, and 30.2:
- wherein, DMF is dimethylformamide.
Dependencies are inferred from the claim text.